首页 | 本学科首页   官方微博 | 高级检索  
     

双黄连注射剂不良反应回顾性研究
引用本文:任经天 吴晔 颜敏 郭晓昕 程鲁榕 刘佳 张承绪 曹立亚. 双黄连注射剂不良反应回顾性研究[J]. 药物流行病学杂志, 2004, 13(4): 188-191,198
作者姓名:任经天 吴晔 颜敏 郭晓昕 程鲁榕 刘佳 张承绪 曹立亚
作者单位:1. 国家食品药品监督管理局药品评价中心,北京,100061
2. 国家食品药品监督管理局药品安全监管司评价处
3. 国家食品药品监督管理局药品审评中心
摘    要:目的:了解双黄连注射剂不良反应类型及其发生率,探索药物流行病学方法在药品安全性评价中的应用。方法:采用病历回顾性研究法,对北京等6省市16家医院4382份使用双黄连注射剂的完整住院病历进行调查,用SPSS11.5进行统计分析。结果:双黄连注射剂主要不良反应为变态反应(发生率2.24%),其中以皮疹(1.69%)最为常见;胃肠道反应(1.51%)以恶心、呕吐、腹痛、腹泻为常见;其他不良反应包括发热(0.64%)、心脑血管反应(0.43%)、胸闷心悸(0.32%)。结论:病历回顾性研究方法适用于药品的安全性研究。双黄连注射剂的常见不良反应应引起临床医生的重视。有必要修改其药品说明书,并对其不良反应进行深入研究。

关 键 词:双黄连注射剂 药品不良反应 回顾性研究 上市后再评价 药物流行病学
文章编号:1005-0698(2004)04-0188-05

Case Retrospective Study of Adverse Drug Reaction of Shuanghuanglian Injection
Ren Jingtian,Wu Ye,Yan Min,Guo XiaoxinCheng Lurong,Liu Ji,Zhang Chengxu,Cao Liya. Center For Drug Reevaluation,SFDA,Beijing,P.R.China. Case Retrospective Study of Adverse Drug Reaction of Shuanghuanglian Injection[J]. Chinese Journal of Pharmacoepidemiology, 2004, 13(4): 188-191,198
Authors:Ren Jingtian  Wu Ye  Yan Min  Guo XiaoxinCheng Lurong  Liu Ji  Zhang Chengxu  Cao Liya. Center For Drug Reevaluation  SFDA  Beijing  P.R.China
Affiliation:Ren Jingtian~1,Wu Ye~1,Yan Min~2,Guo Xiaoxin~1Cheng Lurong~3,Liu Jia~1,Zhang Chengxu~1,Cao Liya~11. Center For Drug Reevaluation,SFDA,Beijing 100061,P.R.China, 2. Division of Evaluation of Drug Safety Monitoring Department,SFDA,3. Center of Drug Evaluation,SFDA
Abstract:Objective: To investigate the adverse reaction types and their incidence rates of shuanghuanglian injection, and explore the application of pharmacoepidemiology methods to drug safety reevaluation.Method: By means of case retrospective study, we have investigated 4382 integrated cases used shuanghuanglian injection in 16 hospitals respectively located in six provinces and cities, such as Beijing city, and so on. The results were statistically analyzed by SPSS (version )11.5)).Result: the main ADRs of shuanghuanglian injection respectively were allergic reactions (incidence )2.24%)), with rash )1.69%), and then gastrointestinal reactions )1.51%), including nausea, vomit, bellyache and diarrhea. The incidence rate of fever was )0.64%), and cardio-cerebrovascular reactions )0.43%), with chest distress and palpitation symptoms )0.32%).Conclusion: Case retrospective study is suitable for drug reevaluation. More attention should be paid to the common ADRs of shuanghuanglian injection by doctors. The drug labeling should be modified, and the ADRs of shuanghuanglian injection should be studied deeply.
Keywords:Shuanghuanglian Injection  Adverse drug reaction  Retrospective study  Post-marketing reevaluation  Pharmacoepidemiology
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号